Related Experiment Video
Updated: Jun 25, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Non-pharmacological interventions for reducing anxiety and depression symptoms among adolescents and young adults:
Gerald Agyapong-Opoku1, Belinda Agyapong1,2, Temitayo Sodunke3
1Department of Psychiatry, University of Alberta, Edmonton, Canada.
Background:
Anxiety and depression are leading causes of mental health-related disability among adolescents and young adults worldwide. These conditions often begin in adolescence and can persist into adulthood, with long-term consequences for individuals' well-being, education, and social functioning. Although a growing number of interventions have been developed to address these concerns, they vary widely in format, setting, and target population.
Objective:
This scoping review aims to systematically map the range and characteristics of interventions targeting anxiety and depression among adolescents and young adults aged 10-24.
Methods:
This scoping review will be conducted following the Joanna Briggs Institute (JBI) methodological guidance for scoping reviews and reported in accordance with the PRISMA-ScR checklist. A comprehensive search will be undertaken across several electronic databases (PubMed, PsycINFO, Scopus, CINAHL, Web of Science, and Embase). Eligible studies will include any empirical research focused on interventions aimed at reducing symptoms of anxiety or depression among individuals aged 10-24 years. Two independent reviewers will select and chart the studies, and findings will be summarized using descriptive and thematic analysis.
Results:
The findings will provide an overview of interventions adopted to reduce anxiety and depression among adolescence across diverse settings, identify the most popular or commonly accepted interventions among this cohort and its modalities. The findings will also highlight the need for stakeholders and policymakers to support the design, implementation, and evaluation of targeted mental health strategies for adolescents and young adults.
Dissemination:
Findings will be published in a peer-reviewed journal and shared with stakeholders including researchers, clinicians, and policymakers. The results will inform future research, intervention development, and policy planning aimed at supporting the mental health of adolescents and young adults.
Related Concept Videos
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Antidepressant Drugs: MAOIs and Other Agents
Stress Prevention and Stress Management Techniques III
The Role of Exercise in Stress Management
Regular physical activity is essential for reducing stress and promoting cardiovascular health. Exercise strengthens the heart, enhances blood flow, keeps blood vessels flexible, and helps lower blood pressure, all of which reduce the body's stress response. Research shows that adults who exercise regularly have nearly half the risk...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.